Cargando…
Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization
Endothelial cell (EC) transplantation via injectable collagen hydrogel has received much attention as a potential treatment for various vascular diseases. However, the therapeutic effect of transplanted ECs is limited by their poor viability, which partially occurs as a result of cellular apoptosis...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403189/ https://www.ncbi.nlm.nih.gov/pubmed/32850742 http://dx.doi.org/10.3389/fbioe.2020.00890 |
_version_ | 1783566901653274624 |
---|---|
author | Hao, Dake Liu, Ruiwu Gao, Kewa He, Chuanchao He, Siqi Zhao, Cunyi Sun, Gang Farmer, Diana L. Panitch, Alyssa Lam, Kit S. Wang, Aijun |
author_facet | Hao, Dake Liu, Ruiwu Gao, Kewa He, Chuanchao He, Siqi Zhao, Cunyi Sun, Gang Farmer, Diana L. Panitch, Alyssa Lam, Kit S. Wang, Aijun |
author_sort | Hao, Dake |
collection | PubMed |
description | Endothelial cell (EC) transplantation via injectable collagen hydrogel has received much attention as a potential treatment for various vascular diseases. However, the therapeutic effect of transplanted ECs is limited by their poor viability, which partially occurs as a result of cellular apoptosis triggered by the insufficient cell-extracellular matrix (ECM) engagement. Integrin binding to the ECM is crucial for cell anchorage to the surrounding matrix, cell spreading and migration, and further activation of intracellular signaling pathways. Although collagen contains several different types of integrin binding sites, it still lacks sufficient specific binding sites for ECs. Previously, using one-bead one-compound (OBOC) combinatorial technology, we identified LXW7, an integrin αvβ3 ligand, which possessed a strong binding affinity to and enhanced functionality of ECs. In this study, to improve the EC-matrix interaction, we developed an approach to molecularly conjugate LXW7 to the collagen backbone, via a collagen binding peptide SILY, in order to increase EC specific integrin binding sites on the collagen hydrogel. Results showed that in the in vitro 2-dimensional (2D) culture model, the LXW7-treated collagen surface significantly improved EC attachment and survival and decreased caspase 3 activity in an ischemic-mimicking environment. In the in vitro 3-dimensional (3D) culture model, LXW7-modified collagen hydrogel significantly improved EC spreading, proliferation, and survival. In a mouse subcutaneous implantation model, LXW7-modified collagen hydrogel improved the engraftment of transplanted ECs and supported ECs to form vascular network structures. Therefore, LXW7-functionalized collagen hydrogel has shown promising potential to improve vascularization in tissue regeneration and may be used as a novel tool for EC delivery and the treatment of vascular diseases. |
format | Online Article Text |
id | pubmed-7403189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74031892020-08-25 Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization Hao, Dake Liu, Ruiwu Gao, Kewa He, Chuanchao He, Siqi Zhao, Cunyi Sun, Gang Farmer, Diana L. Panitch, Alyssa Lam, Kit S. Wang, Aijun Front Bioeng Biotechnol Bioengineering and Biotechnology Endothelial cell (EC) transplantation via injectable collagen hydrogel has received much attention as a potential treatment for various vascular diseases. However, the therapeutic effect of transplanted ECs is limited by their poor viability, which partially occurs as a result of cellular apoptosis triggered by the insufficient cell-extracellular matrix (ECM) engagement. Integrin binding to the ECM is crucial for cell anchorage to the surrounding matrix, cell spreading and migration, and further activation of intracellular signaling pathways. Although collagen contains several different types of integrin binding sites, it still lacks sufficient specific binding sites for ECs. Previously, using one-bead one-compound (OBOC) combinatorial technology, we identified LXW7, an integrin αvβ3 ligand, which possessed a strong binding affinity to and enhanced functionality of ECs. In this study, to improve the EC-matrix interaction, we developed an approach to molecularly conjugate LXW7 to the collagen backbone, via a collagen binding peptide SILY, in order to increase EC specific integrin binding sites on the collagen hydrogel. Results showed that in the in vitro 2-dimensional (2D) culture model, the LXW7-treated collagen surface significantly improved EC attachment and survival and decreased caspase 3 activity in an ischemic-mimicking environment. In the in vitro 3-dimensional (3D) culture model, LXW7-modified collagen hydrogel significantly improved EC spreading, proliferation, and survival. In a mouse subcutaneous implantation model, LXW7-modified collagen hydrogel improved the engraftment of transplanted ECs and supported ECs to form vascular network structures. Therefore, LXW7-functionalized collagen hydrogel has shown promising potential to improve vascularization in tissue regeneration and may be used as a novel tool for EC delivery and the treatment of vascular diseases. Frontiers Media S.A. 2020-07-29 /pmc/articles/PMC7403189/ /pubmed/32850742 http://dx.doi.org/10.3389/fbioe.2020.00890 Text en Copyright © 2020 Hao, Liu, Gao, He, He, Zhao, Sun, Farmer, Panitch, Lam and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Hao, Dake Liu, Ruiwu Gao, Kewa He, Chuanchao He, Siqi Zhao, Cunyi Sun, Gang Farmer, Diana L. Panitch, Alyssa Lam, Kit S. Wang, Aijun Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization |
title | Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization |
title_full | Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization |
title_fullStr | Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization |
title_full_unstemmed | Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization |
title_short | Developing an Injectable Nanofibrous Extracellular Matrix Hydrogel With an Integrin αvβ3 Ligand to Improve Endothelial Cell Survival, Engraftment and Vascularization |
title_sort | developing an injectable nanofibrous extracellular matrix hydrogel with an integrin αvβ3 ligand to improve endothelial cell survival, engraftment and vascularization |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403189/ https://www.ncbi.nlm.nih.gov/pubmed/32850742 http://dx.doi.org/10.3389/fbioe.2020.00890 |
work_keys_str_mv | AT haodake developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT liuruiwu developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT gaokewa developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT hechuanchao developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT hesiqi developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT zhaocunyi developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT sungang developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT farmerdianal developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT panitchalyssa developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT lamkits developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization AT wangaijun developinganinjectablenanofibrousextracellularmatrixhydrogelwithanintegrinavb3ligandtoimproveendothelialcellsurvivalengraftmentandvascularization |